Swedish test may boost pancreatic cancer survival rates

Swedish researchers have developed a new method for diagnosing pancreatic cancer at a much earlier stage than currently possible, the University of Gothenburg said Tuesday.

The test detects the first signs of the with 97 percent accuracy, which researchers hope will help improve the low survival rate among those diagnosed.

Only five percent of patients with pancreatic cancer survive more than five years after their diagnosis as tumours often develop unnoticed and spread to other organs before being detected.

"We are very hopeful that the method will enable more instances of early discovery of at a stage when the cancer can be treated or prevented," Karolina Jabbar, part of the research team at the Sahlgrenska Academy, said in a statement.

"Thanks to this analysis, we can see at what stage the is," she told AFP.

The test works like a normal endoscopy, where a tube is placed inside a patient's mouth and then fed down into the stomach.

"The difference is that the tube takes ultra sound (images) so you can see the organ much better and then you can take off fluids," said Jabbar.

The procedure is not only expected to help detect cancers early but also reduce the risk of unnecessary surgery.

Existing tumours can be tested with the method, with an of about 90 percent, making it easier to determine if a patient needs immediate surgery.

add to favorites email to friend print save as pdf

Related Stories

Pancreatic cancer surgery findings presented at SSO

Mar 13, 2014

Despite the benefits of surgery for early stage pancreatic cancer, it remains under-utilized for patients with this deadly disease, according to a new national analysis of trends and outcomes. Physician-scientists at University ...

A simple test may catch early pancreatic cancer

Oct 23, 2013

Reporting on a small preliminary study, Johns Hopkins researchers say a simple blood test based on detection of tiny epigenetic alterations may reveal the earliest signs of pancreatic cancer, a disease that is nearly always ...

Recommended for you

How a common antacid could lead to cheaper anti-cancer drugs

11 minutes ago

A popular indigestion medication can increase survival in colorectal cancer, according to research published in ecancermedicalscience. But in fact, scientists have studied this for years - and a group of cancer advocates want t ...

Vaccines may make war on cancer personal

22 minutes ago

In the near future, physicians may treat some cancer patients with personalized vaccines that spur their immune systems to attack malignant tumors. New research led by scientists at Washington University ...

Funding to investigate an alternative to chemotherapy

1 hour ago

Professor Simon Rule, Professor in Haematology at Plymouth University Peninsula Schools of Medicine and Dentistry and Consultant Haematologist at Plymouth Hospitals NHS Trust, has been awarded a significant grant by Cancer ...

Enzyme may be key to cancer progression in many tumors

1 hour ago

Mutations in the KRAS gene have long been known to cause cancer, and about one third of solid tumors have KRAS mutations or mutations in the KRAS pathway. KRAS promotes cancer formation not only by driving ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.